The role of lithotripsy and its side effects
- PMID: 2645438
- DOI: 10.1016/s0022-5347(17)41012-3
The role of lithotripsy and its side effects
Abstract
The relative roles of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy currently are being debated. Both treatment modalities are applicable to most upper urinary tract calculi. However, there are some important distinctions between the 2 techniques. Over-all, extra-corporeal shock wave lithotripsy is associated with significantly lower morbidity than percutaneous nephrostolithotomy but stone-free rates are lower for extracorporeal shock wave lithotripsy than for percutaneous nephrostolithotomy. This difference is slight for kidneys containing minimal stone burden but increases in direct proportion to increasing stone burden. The morbidity of extracorporeal shock wave lithotripsy also increases with increasing stone burden. When applied to the treatment of staghorn calculi the morbidity of both techniques is comparable but the stone-free rates are significantly better with percutaneous nephrostolithotomy. Treatment with extracorporeal shock wave lithotripsy produces changes in the kidney similar to that of renal trauma, consisting primarily of intraparenchymal and perirenal hemorrhage and edema. While the acute effects of extracorporeal shock wave lithotripsy are well tolerated by most patients, the long-term sequela of this form of therapy is not well established. Potential long-term adverse effects reported include loss of renal function, hypertension and an increased rate of new stone occurrence. The effect of shock waves on renal parenchyma in experimental animals is dose-dependent (number of shock waves). Magnetic resonance imaging of patients treated with extracorporeal shock wave lithotripsy demonstrates morphological abnormalities in or around the kidney in 63 to 85 per cent of the cases (average number of shock waves 1,200). Despite these observations the safe limits of extracorporeal shock wave lithotripsy in humans have yet to be established. Further study regarding this issue and the potential long-term adverse effects of extracorporeal shock wave lithotripsy is needed urgently.
Similar articles
-
Comparison of results and morbidity of percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy.J Urol. 1987 Sep;138(3):485-90. doi: 10.1016/s0022-5347(17)43236-8. J Urol. 1987. PMID: 3625845
-
Extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for urinary calculi: comparison of immediate and long-term effects.J Stone Dis. 1993 Jan;5(1):8-18. J Stone Dis. 1993. PMID: 10148257
-
Staghorn calculi: analysis of treatment results between initial percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy monotherapy with reference to surface area.J Urol. 1992 May;147(5):1219-25. doi: 10.1016/s0022-5347(17)37522-5. J Urol. 1992. PMID: 1569653
-
Evolution of the technique of combination therapy for staghorn calculi: a decreasing role for extracorporeal shock wave lithotripsy.J Urol. 1992 Sep;148(3 Pt 2):1058-62. doi: 10.1016/s0022-5347(17)36816-7. J Urol. 1992. PMID: 1507330 Review.
-
Complications of renal extracorporeal shock wave lithotripsy reviewed.Urol Radiol. 1992;13(3):139-45. doi: 10.1007/BF02924608. Urol Radiol. 1992. PMID: 1539402 Review.
Cited by
-
An experimentally-calibrated damage mechanics model for stone fracture in shock wave lithotripsy.Int J Fract. 2018 May;211(1-2):203-216. doi: 10.1007/s10704-018-0283-x. Epub 2018 Apr 19. Int J Fract. 2018. PMID: 30349151 Free PMC article.
-
Epidemiology of Kidney Stones.Healthcare (Basel). 2023 Feb 2;11(3):424. doi: 10.3390/healthcare11030424. Healthcare (Basel). 2023. PMID: 36766999 Free PMC article. Review.
-
Global trends in research on extracorporeal shock wave therapy (ESWT) from 2000 to 2021.BMC Musculoskelet Disord. 2023 Apr 20;24(1):312. doi: 10.1186/s12891-023-06407-9. BMC Musculoskelet Disord. 2023. PMID: 37081473 Free PMC article.
-
Effect of SWL on renal hemodynamics: could a change in renal artery contraction-relaxation responses be the cause?Urol Res. 2012 Dec;40(6):775-80. doi: 10.1007/s00240-012-0504-0. Epub 2012 Sep 4. Urol Res. 2012. PMID: 22945811
-
Ischemia and loss of ATP in tumours following treatment with focused high energy shock waves.Br J Cancer. 1993 Jul;68(1):26-31. doi: 10.1038/bjc.1993.281. Br J Cancer. 1993. PMID: 8318417 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources